Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Barnes

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Gastroenterology|May 12, 2005
Serotonin excites neurons in the human submucous plexus via 5-HT3 receptorsKlaus Michel, Florian Zeller, Rupert Langer, et al.
NPJ Regenerative Medicine|January 8, 2021
ILB<sup>®</sup> resolves inflammatory scarring and promotes functional tissue repairLisa J Hill, Hannah F Botfield, Ghazala Begum, et al.
FEBS Open Bio|December 12, 2017
<i>N</i>-glycosylation and expression in human tissues of the orphan GPR61 receptorPaweł Kozielewicz, Hatun Alomar, Syaratul Yusof, et al.
British Journal of Pharmacology|January 17, 2016
Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivoFilippo Andreetta, Lucia Carboni, Gillian Grafton, et al.
Antioxidants (Basel, Switzerland)|September 15, 2020
Low Molecular Weight Dextran Sulfate (ILB<sup>®</sup>) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the RatGiacomo Lazzarino, Angela Maria Amorini, Nicholas M Barnes, et al.
International Immunopharmacology|December 3, 2016
Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: A clinical trial supporting anti-viral indicationsS Rumel Ahmed, Amy S Newman, James O'Daly, et al.
Plos One|May 25, 2022
A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral SclerosisAnn Logan, Zsuzsanna Nagy, Nicholas M Barnes, et al.
British Journal of Pharmacology|September 29, 2016
Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT<sub>3</sub> A receptorAndrew D Powell, Gillian Grafton, Alexander Roberts, et al.
Neuropharmacology|September 13, 2008
Importance of the C-terminus of the human 5-HT3A receptor subunitAmy S Butler, Sarah A Lindesay, Terri J Dover, et al.
Brain, Behavior, & Immunity - Health|October 18, 2021
T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectivesFabiana Corsi-Zuelli, Bill Deakin, Mikhael Haruo Fernandes de Lima, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Gastroenterology|May 12, 2005
Serotonin excites neurons in the human submucous plexus via 5-HT3 receptorsKlaus Michel, Florian Zeller, Rupert Langer, et al.
NPJ Regenerative Medicine|January 8, 2021
ILB<sup>®</sup> resolves inflammatory scarring and promotes functional tissue repairLisa J Hill, Hannah F Botfield, Ghazala Begum, et al.
FEBS Open Bio|December 12, 2017
<i>N</i>-glycosylation and expression in human tissues of the orphan GPR61 receptorPaweł Kozielewicz, Hatun Alomar, Syaratul Yusof, et al.
British Journal of Pharmacology|January 17, 2016
Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivoFilippo Andreetta, Lucia Carboni, Gillian Grafton, et al.
Antioxidants (Basel, Switzerland)|September 15, 2020
Low Molecular Weight Dextran Sulfate (ILB<sup>®</sup>) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the RatGiacomo Lazzarino, Angela Maria Amorini, Nicholas M Barnes, et al.
International Immunopharmacology|December 3, 2016
Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: A clinical trial supporting anti-viral indicationsS Rumel Ahmed, Amy S Newman, James O'Daly, et al.
Plos One|May 25, 2022
A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral SclerosisAnn Logan, Zsuzsanna Nagy, Nicholas M Barnes, et al.
British Journal of Pharmacology|September 29, 2016
Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT<sub>3</sub> A receptorAndrew D Powell, Gillian Grafton, Alexander Roberts, et al.
Neuropharmacology|September 13, 2008
Importance of the C-terminus of the human 5-HT3A receptor subunitAmy S Butler, Sarah A Lindesay, Terri J Dover, et al.
Brain, Behavior, & Immunity - Health|October 18, 2021
T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectivesFabiana Corsi-Zuelli, Bill Deakin, Mikhael Haruo Fernandes de Lima, et al.
Pageof 8